DAWN- Day One Biopharmaceuticals, Inc.

Name: Day One Biopharmaceuticals, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Day One Biopharmaceuticals, Inc. (DAWN) has 13 insiders with recent SEC Form 4 filings, including 0 buys and 33 sells. DAWN is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	Bender Jeremy	355.0K	$7.64M	-
CFO	York Charles N II	188.0K	$4.05M	-
Other	Vasconcelles Michael	171.0K	$3.68M	-
Other	Dubow Adam	105.0K	$2.26M	-
Other	Merendino Lauren	74.0K	$1.59M	-

Activity

Buys and sells only

Transactions

10 filings · page 10

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Sep 21, 2022	Canaan XI L.P.72	10% Owner	Sell	613,603	$18.55	$11,380,779.12	-3.5%	+11.5%	-29.0%
Sep 21, 2022	Grant Julie Papanek78	Director	Sell	613,603	$18.55	$11,380,779.12	-3.5%	+11.5%	-29.0%
Sep 20, 2022	Grant Julie Papanek78	Director	Sell	340,702	$20.44	$6,963,115.78	-0.7%	+0.6%	-33.3%
Sep 20, 2022	Canaan XI L.P.72	10% Owner	Sell	340,702	$20.44	$6,963,115.78	-0.7%	+0.6%	-33.3%
Sep 15, 2022	Grant Julie Papanek78	Director	Sell	245,039	$23.76	$5,823,084.06	-0.4%	-5.1%	-38.9%
Sep 15, 2022	Canaan XI L.P.72	10% Owner	Sell	245,039	$23.76	$5,823,084.06	-0.4%	-5.1%	-38.9%
Sep 2, 2022	Grant Papanek Julie78	Director	Sell	5,000	$23.82	$119,107.50	-1.1%	-10.8%	-41.3%
Sep 1, 2022	Grant Papanek Julie78	Director	Sell	5,000	$23.27	$116,358.38	-0.6%	-10.6%	-41.2%
Sep 1, 2022	York Charles N II76	COO, CFO And Secretary	Sell	10,000	$23.25	$232,484.32	-1.6%	-10.6%	-41.2%
Sep 1, 2022	Blackman Samuel C.77	Chief Medical Officer	Sell	10,000	$23.25	$232,451.50	-0.4%	-10.6%	-41.2%

← PrevPage 10Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC